Neo Ivy Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,587
| Closed | -$290K | – | 678 |
|
|
2021
Q3 | $290K | Buy |
+2,587
| New | +$290K | 0.33% | 111 |
|
|
2020
Q3 | – | Sell |
-2,587
| Closed | -$290K | – | 663 |
|
|
2020
Q2 | $290K | Buy |
2,587
+2,250
| +668% | +$252K | 0.33% | 111 |
|
|
2020
Q1 | $30K | Buy |
+337
| New | +$30K | 0.05% | 354 |
|
|
2019
Q4 | – | Sell |
-12,798
| Closed | -$1.29M | – | 425 |
|
|
2019
Q3 | $1.29M | Buy |
+12,798
| New | +$1.29M | 0.84% | 1 |
|
|
2019
Q1 | – | Sell |
-6,581
| Closed | -$641K | – | 423 |
|
|
2018
Q4 | $641K | Buy |
+6,581
| New | +$641K | 0.5% | 75 |
|